Enzyme Inhibitors via Transition State Design
The Candidate will join an established team of academic staff and professional scientists working on the development of enzyme inhibitors as new therapeutic drug candidates. The team have a strong record with three compounds in clinical trials and one compound (Mundesine) on the market.
The team employs transition state design technology to discover exceptionally powerful inhibitors of target enzymes. Current enzymes being studied are in the areas of cancer and bacterial resistance.
The scholarship funded by the Maurice Wilkins Centre, would suit a student with a background in organic chemistry or biochemistry who is interested in enzyme mechanism. The project will tackle key enzymes associated with the antibiotic resistance.
Prospective applicants should apply to Emily Parker at [Email Address Removed] for the Maurice Wilkins Centre Scholarship. The vacancies will remain open until suitable applicants are found.
The Stipend is $27,500 pa and full fees will be paid. Those applying should attach their CV, full academic transcript, statement of research interests and the names of three referees to their letter of application.